FDA Inspection
The Methodist Hospital Research InstituteThe Methodist Hospital Research Institute – FDA Inspection, Jul 19, 2024
Record Details
This FDA Inspection record concerns The Methodist Hospital Research Institute, with an inspection on July 19, 2024, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 9c89527e-4bc7-4def-911d-bac41b9aa5c9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1244364
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination
- 21 CFR 212.40(b)Written specifications - components
- 21 CFR 212.50(c)(4)Each major production step
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Methodist Hospital Research Institute
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | VAI | Dallas District Office | Drug Quality Assurance |
| November 2, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Methodist Hospital Research Institute
- FDA Inspection 1302066 - 2026-02-13
- FDA Inspection 1070966 - 2018-11-02
- FDA Inspection 892810 - 2014-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.